Genomic Profiling for KRAS, NRAS, BRAF, Microsatellite Instability, and Mismatch Repair Deficiency Among Patients With Metastatic Colon Cancer

PURPOSE: Genomic testing is recognized in national guidelines as essential to guide appropriate therapy selection in metastatic colorectal cancer. Previous studies report adherence to testing guidelines is suboptimal, but current testing rates have not been assessed. This study reports testing rates...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JCO Precis Oncol
Main Authors: Gutierrez, Martin E., Price, Kristin S., Lanman, Richard B., Nagy, Rebecca J., Shah, Irfan, Mathura, Shivam, Mulcahy, Michael, Norden, Andrew D., Goldberg, Stuart L.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2019
Assuntos:
Original Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448804/
https://ncbi.nlm.nih.gov/pubmed/32923867
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00274
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados